glp-1 grey market now considered on the North America Glucagon-Like Peptide-1 (GLP-1)

30 LiebauE.De MariaF.BurmeisterC.PerbandtM.TurellaP.AntoniniG.et al (2005)

However, these plasma proteins are saturable

Also, given the observational nature of the study, we could expect the presence of indication bias, a type of confounding bias that occurs when a symptom or sign of disease is judged as an indication for a given therapy, and is therefore associated both with the use of a drug and with a higher probability of an outcome related to the disease for which the agent is indicated [37]

With these insights, we create a customized weight loss plan that may include nutritional guidance, exercise recommendations, behavioral counseling, and, when appropriate, FDA-approved prescription medications